SciELO - Scientific Electronic Library Online

vol.5 número2Folie imposée en dos hermanas gemelas índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados




  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO


Medicina clínica y social

versión On-line ISSN 2521-2281


RIVAROLA¹, Karina  y  ORTIZ¹, Ignacio. Therapeutics of posterior reversible encephalopathy: a systematic review. Med. clín. soc. [online]. 2021, vol.5, n.2, pp.84-89. ISSN 2521-2281.


Posterior reversible encephalopathy syndrome PRES (also known as posterior reversible leukoencephalopathy syndrome) presents with rapid-onset symptoms such as headache, seizures, altered consciousness, and visual impairment. Often, but by no means always, it is associated with acute hypertension.


Systematic literature review type study. A systematic review of the literature was carried out in the PubMed / MEDLINE, LILACS and CICCO databases using the syntax “Posterior reversible encephalopathy syndrome AND treatment”. The search limits were publications made in the last five years (2013-2020).


235 full texts were evaluated, of which six were finally selected, taking into account that the other articles did not explicitly mention the treatment, or were redundant with respect to others already included, taking into account that the PRES has symptomatic rather than specific treatment.


Posterior Reversible Encephalopathy Syndrome (PRES) does not have a specific treatment, but rather has a symptomatic treatment, which makes it essential to know the underlying causes of PRES since that is the therapy to follow, to provide the best treatment for what is causing this syndrome, hence the importance of fully understanding the etiology.

Palabras clave : Encephalopathies; Posterior Leukoencephalopaia Syndrome; Therapy.

        · resumen en Español     · texto en Español     · Español ( pdf )